Boditech Med

Boditech Med EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Boditech Med (206640.KQ) as of Nov 4, 2026 is 28.94 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 30.69 B KRW — a change of -5.70% (lower).

EBITDA

28.94 BKRW

YoY

-5.70%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Boditech Med is 2025 28.94 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Boditech Med was 2024 30.69 B KRW. It decreases by -5.70% lower compared to the previous year.

The Boditech Med EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
656.23 M KRW
Jan 1, 2019
16.65 B KRW
Jan 1, 2020
65.54 B KRW
Jan 1, 2021
54.19 B KRW
Jan 1, 2022
28.11 B KRW
Jan 1, 2023
33.30 B KRW
Jan 1, 2024
30.69 B KRW
Jan 1, 2025
28.94 B KRW
The Boditech Med EBITDA history
YEAREBITDAYoY
28.94 BKRW-5.70%
30.69 BKRW-7.84%
33.30 BKRW+18.48%
28.11 BKRW-48.13%
54.19 BKRW-17.32%
65.54 BKRW+293.55%
16.65 BKRW+2,437.77%
656.23 MKRW-295.42%
-335.80 MKRW-102.48%
13.53 BKRW+4.22%
12.98 BKRW-99,931.35%
-13.00 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Boditech Med Stock analysis

What does Boditech Med do? Boditech Med, Inc. generates revenue through the manufacture and sale of in-vitro diagnostics analyzers and reagents, including antigen diagnostic kits, cancer diagnostic kits, and drug concentration diagnostic kits. The company serves domestic and overseas markets with its products, focusing on diagnostic solutions for healthcare providers and laboratories. Its product portfolio targets medical professionals seeking reliable testing tools for disease detection and treatment monitoring. The firm's primary customers are healthcare institutions and diagnostic laboratories that require specialized testing equipment and consumables. By offering a range of diagnostic kits for various medical applications, Boditech Med addresses the needs of both local and international clients in the healthcare sector. The company's products are designed to support clinical decision-making through accurate and efficient diagnostic processes. Boditech Med is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Boditech Med stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Boditech Med is 28.94 B KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Boditech Med changed from 30.69 B KRW to 28.94 B KRW, representing a -5.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Boditech Med since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Boditech Med historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Boditech Med

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Boditech Med